Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease. (NCT04515290) | Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd. | 2020-05-07 |
Track Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.